Frontiers in Pharmacology

Sirolimus application in patients with autoimmune-associated kidney diseases based on mTORC1 activation: a preliminary exploration and future perspectives

Trial in peopleInterventions

The paper

Peking University; Peking University International Hospital

Frontiers in Pharmacology, 29 Jul 2026

doi.org/10.3389/fphar.2026.1791188PubMed 42591843